137 related articles for article (PubMed ID: 16233889)
1. Independent component analysis to proton spectroscopic imaging data of human brain tumours.
Pulkkinen J; Häkkinen AM; Lundbom N; Paetau A; Kauppinen RA; Hiltunen Y
Eur J Radiol; 2005 Nov; 56(2):160-4. PubMed ID: 16233889
[TBL] [Abstract][Full Text] [Related]
2. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
Stadlbauer A; Moser E; Gruber S; Buslei R; Nimsky C; Fahlbusch R; Ganslandt O
Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395
[TBL] [Abstract][Full Text] [Related]
3. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
[TBL] [Abstract][Full Text] [Related]
4. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
5. Spectrum separation resolves partial-volume effect of MRSI as demonstrated on brain tumor scans.
Su Y; Thakur SB; Karimi S; Du S; Sajda P; Huang W; Parra LC
NMR Biomed; 2008 Nov; 21(10):1030-42. PubMed ID: 18759383
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance spectroscopic imaging for visualization of the infiltration zone of glioma.
Stadlbauer A; Buchfelder M; Doelken MT; Hammen T; Ganslandt O
Cent Eur Neurosurg; 2011 May; 72(2):63-9. PubMed ID: 20635312
[TBL] [Abstract][Full Text] [Related]
7. In vitro study of astrocytic tumour metabolism by proton magnetic resonance spectroscopy.
Likavcanová K; Dobrota D; Liptaj T; Prónayová N; Mlynárik V; Belan V; Galanda M; Béres A; De Riggo J
Gen Physiol Biophys; 2005 Sep; 24(3):327-35. PubMed ID: 16308427
[TBL] [Abstract][Full Text] [Related]
8. MR imaging in cerebral gliomas. Tissue component analysis in correlation with histopathology of whole-brain specimens.
Tovi M; Hartman M; Lilja A; Ericsson A
Acta Radiol; 1994 Sep; 35(5):495-505. PubMed ID: 8086262
[TBL] [Abstract][Full Text] [Related]
9. Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy.
Meyerand ME; Pipas JM; Mamourian A; Tosteson TD; Dunn JF
AJNR Am J Neuroradiol; 1999 Jan; 20(1):117-23. PubMed ID: 9974066
[TBL] [Abstract][Full Text] [Related]
10. Fast spectroscopic imaging strategies for potential applications in fMRI.
Mulkern RV; Chen NK; Oshio K; Panych LP; Rybicki FJ; Gambarota G
Magn Reson Imaging; 2004 Dec; 22(10):1395-405. PubMed ID: 15707789
[TBL] [Abstract][Full Text] [Related]
11. Classification of malignant gliomas by infrared spectroscopy and linear discriminant analysis.
Krafft C; Thümmler K; Sobottka SB; Schackert G; Salzer R
Biopolymers; 2006 Jul; 82(4):301-5. PubMed ID: 16506167
[TBL] [Abstract][Full Text] [Related]
12. Fast nosologic imaging of the brain.
De Vos M; Laudadio T; Simonetti AW; Heerschap A; Van Huffel S
J Magn Reson; 2007 Feb; 184(2):292-301. PubMed ID: 17118683
[TBL] [Abstract][Full Text] [Related]
13. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
Fayed N; Morales H; Modrego PJ; Pina MA
Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
[TBL] [Abstract][Full Text] [Related]
14. Tissue characterization of glioma by proton magnetic resonance spectroscopy and perfusion-weighted magnetic resonance imaging: glioma grading and histological correlation.
Toyooka M; Kimura H; Uematsu H; Kawamura Y; Takeuchi H; Itoh H
Clin Imaging; 2008; 32(4):251-8. PubMed ID: 18603178
[TBL] [Abstract][Full Text] [Related]
15. The use of proton MRS in the differential diagnosis of brain tumors and tumor-like processes.
Gajewicz W; Papierz W; Szymczak W; Goraj B
Med Sci Monit; 2003 Sep; 9(9):MT97-105. PubMed ID: 12960934
[TBL] [Abstract][Full Text] [Related]
16. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study.
Tedeschi G; Lundbom N; Raman R; Bonavita S; Duyn JH; Alger JR; Di Chiro G
J Neurosurg; 1997 Oct; 87(4):516-24. PubMed ID: 9322842
[TBL] [Abstract][Full Text] [Related]
17. Comments and controversies: magnetic resonance spectroscopy and gliomas.
Fan G
Cancer Imaging; 2006 Sep; 6(1):113-5. PubMed ID: 16966066
[TBL] [Abstract][Full Text] [Related]
18. 3D 1H MRSI of brain tumors at 3.0 Tesla using an eight-channel phased-array head coil.
Osorio JA; Ozturk-Isik E; Xu D; Cha S; Chang S; Berger MS; Vigneron DB; Nelson SJ
J Magn Reson Imaging; 2007 Jul; 26(1):23-30. PubMed ID: 17659562
[TBL] [Abstract][Full Text] [Related]
19. In vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi-dimensional classification.
Hagberg G; Burlina AP; Mader I; Roser W; Radue EW; Seelig J
Magn Reson Med; 1995 Aug; 34(2):242-52. PubMed ID: 7476084
[TBL] [Abstract][Full Text] [Related]
20. 3.0-T functional brain imaging: a 5-year experience.
Scarabino T; Giannatempo GM; Popolizio T; Tosetti M; d'Alesio V; Esposito F; Di Salle F; Di Costanzo A; Bertolino A; Maggialetti A; Salvolini U
Radiol Med; 2007 Feb; 112(1):97-112. PubMed ID: 17310287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
